Top Cardiovascular Drug Classes for Pharmacy Techs
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Heart and blood-vessel medicines make up a large share of the prescriptions a community pharmacy fills, and the PTCE content outline expects you to link a generic name to its drug class. This guide covers the major cardiovascular classes: what each one does, common generic examples, the name stems that give the class away, and the safety points a technician should recognize and bring to the pharmacist. It is a study aid, not clinical advice. Counseling and clinical judgment belong to the pharmacist. The table gives the overview; each section below adds detail.
| Class | Name clue | Generic examples | Flag to the pharmacist |
|---|---|---|---|
| Statins | -vastatin | atorvastatin, rosuvastatin, simvastatin, pravastatin | muscle pain, interacting drugs |
| ACE inhibitors | -pril | lisinopril, enalapril, benazepril, ramipril | dry cough, facial swelling, pregnancy |
| ARBs | -sartan | losartan, valsartan, olmesartan, irbesartan | pregnancy, potassium, ACE + ARB together |
| Beta blockers | -olol (also -alol, -dilol) | metoprolol, atenolol, propranolol, labetalol, carvedilol | stopping suddenly |
| Calcium channel blockers | -dipine (one subgroup) | amlodipine, nifedipine, verapamil, diltiazem | ankle swelling, interactions |
| Diuretics | no single stem (some end in -thiazide) | hydrochlorothiazide, chlorthalidone, furosemide, spironolactone | potassium changes |
| Anticoagulants | -parin, -xaban, -gatran | warfarin, heparin, enoxaparin, apixaban, rivaroxaban, dabigatran | bleeding, monitoring |
| Antiplatelets | -grel | aspirin, clopidogrel, prasugrel, ticagrelor | bleeding, interactions |
Statins
Statins block HMG-CoA reductase, the liver enzyme that controls a key step in making cholesterol, which lowers LDL ("bad") cholesterol. Every statin ends in -vastatin: atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin.
Points to recognize:
- Muscle symptoms. Unexplained muscle pain, tenderness or weakness can signal myopathy and, rarely, rhabdomyolysis. These reports go to the pharmacist.
- Interactions. The simvastatin label lists strong CYP3A4 inhibitors such as clarithromycin as contraindicated, caps simvastatin at 10 mg a day with verapamil, diltiazem or dronedarone and at 20 mg with amiodarone, amlodipine or ranolazine, and tells patients to avoid grapefruit juice, which raises simvastatin levels and the risk of muscle injury.
- 2012 FDA label changes. Routine periodic liver enzyme testing is no longer recommended (test before starting and then as clinically needed), and labels now mention reversible memory problems and small increases in blood sugar.
ACE inhibitors and ARBs
Both classes act on the renin-angiotensin system, which raises blood pressure. ACE inhibitors (-pril) block the enzyme that makes angiotensin II. Angiotensin II receptor blockers, or ARBs (-sartan), block angiotensin II at its receptor. Both are used for high blood pressure, and certain members have other labeled uses such as heart failure.
Points to recognize:
- Dry cough. A nagging, dry cough is a classic ACE inhibitor side effect. ARBs work one step later in the pathway and are far less likely to cause it, which is why a prescriber may switch a patient from a -pril to a -sartan.
- Angioedema. Swelling of the face, lips, tongue or throat is an emergency. A history of angioedema from an ACE inhibitor is a contraindication in the lisinopril label.
- Pregnancy. Both classes carry a boxed warning for fetal toxicity: drugs acting on the renin-angiotensin system can injure or kill a developing fetus.
- Potassium. These drugs can raise potassium, especially with potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes.
- Duplication. An ACE inhibitor and an ARB on the same profile is dual blockade of the same system and should be flagged.
Beta blockers
Beta blockers block beta-adrenergic receptors, which slows the heart rate and lowers blood pressure. Uses include hypertension, angina and, for some agents, heart failure. Most end in -olol (metoprolol, atenolol, bisoprolol, propranolol, nadolol). Labetalol and carvedilol also block alpha receptors and end differently (-alol, -dilol).
Points to recognize:
- Do not stop suddenly. A boxed warning on metoprolol labels says that abrupt cessation can worsen angina and has led to heart attacks; when stopping, the prescriber tapers the dose, typically over one to two weeks.
- Hypoglycemia masking. Beta blockers can hide the fast heartbeat that warns a person with diabetes of low blood sugar.
- Salt forms matter. Metoprolol tartrate (immediate release) and metoprolol succinate (extended release) are different products. Match the salt on the prescription exactly.
Calcium channel blockers
These drugs block calcium from entering muscle cells in blood vessels and, for some agents, the heart. There are two groups:
- Dihydropyridines (-dipine): amlodipine, nifedipine, felodipine. They mainly relax arteries; ankle swelling, flushing and headache are common complaints.
- Non-dihydropyridines: verapamil and diltiazem. They also slow the heart rate and do not follow the -dipine stem.
Many come as extended-release products that should not be crushed or split unless the labeling allows it. Verapamil and diltiazem also interact with other drugs, as the simvastatin dose cap above shows.
Diuretics
Diuretics make the kidneys remove more salt and water.
- Thiazide and thiazide-like: hydrochlorothiazide, chlorthalidone. Mainly for blood pressure; can lower potassium.
- Loop: furosemide, bumetanide, torsemide. The most powerful group, used for fluid buildup such as in heart failure; can lower potassium substantially.
- Potassium-sparing: spironolactone, eplerenone, triamterene, amiloride. Can raise potassium, especially alongside an ACE inhibitor or ARB.
A common counseling point is taking a once-daily diuretic in the morning so the extra urination does not interrupt sleep.
Anticoagulants and antiplatelets
Anticoagulants interfere with clotting factors and are used to prevent or treat clots such as deep vein thrombosis and stroke from atrial fibrillation. Antiplatelets stop platelets from clumping and are used after heart attacks, strokes and stent placement.
- Warfarin blocks vitamin K-dependent clotting factors. Its boxed warning is serious bleeding, and every patient needs regular INR checks; the usual target range for most uses is 2.0 to 3.0. Changes in dietary vitamin K and many drug interactions can shift the INR.
- Heparin and enoxaparin (-parin) are injectable anticoagulants.
- Direct oral anticoagulants: apixaban, rivaroxaban and edoxaban (-xaban, factor Xa inhibitors) and dabigatran (-gatran, a direct thrombin inhibitor). They do not need routine INR checks. Apixaban's boxed warnings cover a higher clot risk if it is stopped early and spinal or epidural bleeding with spinal procedures.
- Antiplatelets: aspirin, plus clopidogrel, prasugrel and ticagrelor (-grel). Clopidogrel's boxed warning says it works less well in CYP2C19 poor metabolizers, and its label warns that omeprazole and esomeprazole reduce its effect.
Bleeding risk adds up, so a patient on a blood thinner who buys an OTC NSAID or aspirin, or two blood thinners on one profile, should be referred to the pharmacist.
Key takeaways
- Stems sort most of these drugs fast: -vastatin, -pril, -sartan, -olol, -dipine, -parin, -xaban, -grel.
- Verapamil and diltiazem do not use -dipine (they have their own stems, -pamil and -tiazem), and warfarin and aspirin follow no class stem. Learn them by name.
- ACE inhibitor cough and angioedema, and the fetal-toxicity boxed warning for ACE inhibitors and ARBs, are classic exam points.
- Beta blockers should not be stopped abruptly, and potassium-sparing diuretics plus ACE inhibitors or ARBs can raise potassium.
- Warfarin needs INR monitoring; direct oral anticoagulants do not, but stopping them early raises clot risk.
Quick check
Q1. A patient on lisinopril complains of a persistent dry cough. Which class might the prescriber switch to?
Answer: An ARB such as losartan. ARBs do not block ACE, so they are much less likely to cause the cough.
Q2. Which of these is a calcium channel blocker that does NOT end in -dipine: amlodipine, diltiazem or atenolol?
Answer: Diltiazem. It is a non-dihydropyridine calcium channel blocker; atenolol is a beta blocker.
Q3. Which lab test is checked regularly for warfarin but not routinely for apixaban?
Answer: The INR. Warfarin has a narrow range that diet and drug interactions shift, while apixaban does not need routine INR checks.
Practice these classes and stems in Pillworks Idle.
Sources
- NLM DailyMed — ZOCOR (simvastatin) tablets, prescribing information
- NLM DailyMed — Lisinopril tablets, prescribing information
- NLM DailyMed — Metoprolol tartrate tablets, prescribing information
- NLM DailyMed — Warfarin sodium tablets, prescribing information
- NLM DailyMed — Apixaban tablets, prescribing information
- NLM DailyMed — PLAVIX (clopidogrel) tablets, prescribing information (boxed warning: poor CYP2C19 metabolizers)
- PTCB — PTCE Job Analysis Study and the content outline effective January 6, 2026